Clinical Trial Update: Galantamine Effects in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of galantamine in adults with metabolic syndrome and abdominal obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Abdominal Obesity Metabolic Syndrome | Phase 4 | Status: COMPLETED